At dinner last weekend in Houston, on a break with compadres from the Society of Food Addiction Professionals, I heard about a drug that was coming out any day, and it turns out, it's not!

The Washington Post reports that the FDA has denied approval to a drug called Contrave, which blends "naltrexone, which is used to treat alcohol and drug addiction, and buproprion, which is sold as Wellbutrin when used as an antidepressant and Zyban when used to help people quit smoking," according to reporter Rob Stein.

The greater minds around the table were skeptical of the drug's usefulness, especially because naltexone's effectiveness fades relatively quickly, but the conversation quickly moved on to acknowledging the power of pharmaceutical money.

So, not this time.

One of the changes wrought by my continuing recovery from obesity and food addiction is that, in general, I prefer to forego drugs whenever possible — not slavishly or foolishly, but tending in that direction. And, since I needed lots of support to help me put less food in my mouth, but not pharmacology, I have that reaction this time.

I don't believe, in the main, that drugs are the answer to this problem. Lifestyle changes, all the way.